Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Septic Arthritis of the Shoulder Following Ozone Therapy: A Case Report.

Cureus·2026
Same author

Spinal Subarachnoid Hematoma After Spinal Anesthesia: A Case Report and Literature-Aligned Review.

Cureus·2026
Same author

Association of Erector Spinae Plane Block on Quality of Postoperative Recovery in Patients Undergoing Video-Assisted Thoracoscopic Surgery: An Observational Cohort Study.

Cureus·2026
Same author

Differential metabolic reprogramming due to nitrogen starvation leads to remobilization of storage metabolites in microalgal strains.

Journal of biotechnology·2025
Same author

Heart Failure With Preserved Ejection Fraction and Chronic Kidney Disease: From Pathophysiology to Treatment.

The American journal of cardiology·2025
Same author

Inflammatory Response and Malnutrition Based on the Global Leadership Initiative on Malnutrition: Adults and Older People With Oropharyngeal Dysphagia.

Journal of the American Nutrition Association·2025

Related Experiment Video

Updated: Jul 19, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Sudden death prevention in heart failure.

Mariana Machado1, L Menezes Falcão, Luciano Ravara

  • 1Serviço de Medicina I, Hospital de Santa Maria, Lisboa, Portugal. marianavmachado@hotmail.com

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|October 31, 2006
PubMed
Summary

Sudden cardiac death in heart failure patients can be prevented. Identifying high-risk individuals and optimizing treatment, including implantable cardioverter-defibrillators (ICDs), significantly improves survival and quality of life.

More Related Videos

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Jul 19, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Area of Science:

  • Cardiology
  • Clinical Medicine

Background:

  • Heart failure affects 0.4-2% of Europeans, with 5-20% annual mortality.
  • Sudden death is a common cause of mortality in heart failure patients.
  • Effective risk stratification is crucial for implementing preventive strategies.

Purpose of the Study:

  • To review preventive strategies for sudden death in heart failure.
  • To highlight the role of risk stratification and optimized treatment.
  • To discuss the benefits of implantable cardioverter-defibrillators (ICDs).

Main Methods:

  • Review of current literature on heart failure and sudden death prevention.
  • Analysis of risk factors, including low ejection fraction, ECG, and Holter monitoring.
  • Evaluation of primary prevention strategies and therapeutic interventions.

Main Results:

  • Low ejection fraction is a primary risk factor for sudden death.
  • ECG, Holter monitoring, and electrophysiological studies aid risk assessment.
  • Optimized heart failure treatment and ICD implantation are key preventive measures.

Conclusions:

  • Primary prevention requires identifying and managing reversible factors.
  • ICD implantation is the most effective strategy for selected patients.
  • Combined cardioversion-defibrillation and cardiac resynchronization devices improve outcomes.